Vical, Compugen lead drug stocks north
December 28, 2009 at 10:36 AM EST
BOSTON (MarketWatch) -- Drug stocks edged higher in early action Monday as shares of Vical Inc. rallied on positive news about its gene-based cancer therapy Allovectin-7.
